NAS10029,465−1.17%S&P7,723−0.27%GOLD$4,035−0.40%BTC$81,733+0.57%VIX16.46−2.66%latest tape · as of 16:04 UTC
The Screen · Consumer Cyclical · Auto Parts
Autoliv, Inc.
ALV · the NYSE · USD · Market cap $8.4B · 57,690 employees
Autoliv, Inc., through its subsidiaries, develops, manufactures, and supplies passive safety systems to the automotive industry in the Americas, Europe, China, and Asia.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 2.75, read 2026-10-28
Ethical passes the values gate
Price115.55 USD
Fair value148.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-25Read Accumulation116.49-0.8% to today Markdown gives way to Accumulation
2026-10-11Read Markdown113.07+2.2% to today Distribution gives way to Markdown first Markdown read since September
2026-10-02Read Distribution113.07+2.2% to today Markdown gives way to Distribution after a 7% slide in 11 days
2026-09-21Read Markdown121.13-4.6% to today ✓Markup gives way to Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Autoliv, Inc. holds its Accumulation at $115.55. Consolidating, no directional conviction, held for 368 days.
As held on the ledger · 2026-10-28
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 368 days
Price at the screen
$115.55
Valuation
13.75 trailing · 10.02 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.40
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
26.82%
Below 33%
Interest-bearing debt is just 26.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
32.86%
Below 49%
Money owed to the company is 32.9% of assets, under the 49% limit.
Pass
Revenue purity
0.09%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Autoliv, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ALV's ethical verdict changes
Today ALV passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 28.1% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Safety systems supplier sits in a cyclical trap
Picture every new car rolling off the line with airbags and seatbelts that must work first time. Autoliv supplies those systems across Europe, China and the Americas yet sells into an industry whose volumes rise and fall with economic mood swings. The business clears our ethical screen and shows a 26 percent return on equity, yet we still pass.
Forward earnings sit at just 10.1 times while revenue edges forward only 3 percent a year and net margins remain 6 percent. That combination looks cheap until you remember the company is a pure auto-parts cyclical. Peak-cycle earnings often produce exactly these low multiples; the market has seen this pattern before and is not paying up.
Analysts like the name and place fair value higher, but the 25 percent gap to our own estimate does not create an opportunity. The low multiple is a warning, not a bargain, and growth remains too modest to offset the sector's swings. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Sweden and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ALV trades on the NYSE (the company is based in Sweden). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-10-18Markdown$115.96+2.6%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-10-11Markdown · changed$113.07+0.0%Entry 9
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-09-21Markdown · changed$121.13+0.5%Entry 7
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-08-21Markup · changed$120.57+0.3%Entry 6
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-07-18Markup$128.53+0.0%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-07-17Markup$128.53+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (17 analysts) rates it none, with a mean price target of $132.
2026-07-03Markup$128.53+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
